These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 20025451

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Clinic-based treatment for opioid dependence: a qualitative inquiry.
    McMurphy S, Shea J, Switzer J, Turner BJ.
    Am J Health Behav; 2006; 30(5):544-54. PubMed ID: 16893317
    [Abstract] [Full Text] [Related]

  • 28. Buprenorphine and methadone: a comparison of patient completion rates during inpatient detoxification.
    Blondell RD, Smith SJ, Servoss TJ, DeVaul SK, Simons RL.
    J Addict Dis; 2007; 26(2):3-11. PubMed ID: 17594993
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Comparison of costs and utilization among buprenorphine and methadone patients.
    Barnett PG.
    Addiction; 2009 Jun; 104(6):982-92. PubMed ID: 19466922
    [Abstract] [Full Text] [Related]

  • 31. The impact of community pharmacy dispensing fees on the introduction of buprenorphine - naloxone in Australia.
    Winstock AR, Lea T, Ritter A.
    Drug Alcohol Rev; 2007 Jul; 26(4):411-6. PubMed ID: 17564877
    [Abstract] [Full Text] [Related]

  • 32. Exposure to opioid maintenance treatment reduces long-term mortality.
    Gibson A, Degenhardt L, Mattick RP, Ali R, White J, O'Brien S.
    Addiction; 2008 Mar; 103(3):462-8. PubMed ID: 18190664
    [Abstract] [Full Text] [Related]

  • 33. Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, Australia.
    Winstock AR, Lea T, Sheridan J.
    Addiction; 2010 Feb; 105(2):335-42. PubMed ID: 20078490
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.
    Maas J, Barton G, Maskrey V, Pinto H, Holland R.
    Drug Alcohol Depend; 2013 Dec 01; 133(2):494-501. PubMed ID: 23962419
    [Abstract] [Full Text] [Related]

  • 36. A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia.
    Burns L, Gisev N, Larney S, Dobbins T, Gibson A, Kimber J, Larance B, Mattick RP, Butler T, Degenhardt L.
    Addiction; 2015 Apr 01; 110(4):646-55. PubMed ID: 25516077
    [Abstract] [Full Text] [Related]

  • 37. Feasibility of buprenorphine and methadone maintenance programmes among users of home made opioids in Ukraine.
    Schaub M, Chtenguelov V, Subata E, Weiler G, Uchtenhagen A.
    Int J Drug Policy; 2010 May 01; 21(3):229-33. PubMed ID: 19926271
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Buprenorphine or methadone for detoxification of young opioid addicts?].
    Ebner R, Schreiber W, Zierer C.
    Psychiatr Prax; 2004 Nov 01; 31 Suppl 1():S108-10. PubMed ID: 15570521
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.